Interleukin-10 and tumor necrosis factor-alpha polymorphisms in vascular access failure in patients on hemodialysis: preliminary data in Korea
- PMID: 18303205
- PMCID: PMC2526491
- DOI: 10.3346/jkms.2008.23.1.89
Interleukin-10 and tumor necrosis factor-alpha polymorphisms in vascular access failure in patients on hemodialysis: preliminary data in Korea
Abstract
Neointimal hyperplasia causes vascular stenosis and subsequent thrombosis, which result in vascular access failure in patients undergoing hemodialysis. Interleukin-10 (IL-10) and tumour necrosis factor-alpha(TNF-alpha) are involved in this inflammatory process. The aim of this study was to investigate the relationship between vascular access failure and various inflammatory markers including the genetic polymorphisms of IL-10 and TNF-alpha. Seventy-five patients on hemodialysis with an arteriovenous fistula in place or an artificial graft (18 with vascular access failure and 82 without failure) and 98 healthy individuals were genotyped for IL-10 and TNF-alpha single nucleotide polymorphisms. Clinical and laboratory data including serum IL-10 and TNF-alpha levels were compared. Stimulated IL-10 levels, from in vitro incubation of blood with lipopolysaccharide, were also obtained and compared. Female gender, hypoproteinemia, and hypertriglyceridemia were associated with vascular access failure. The basal TNF-alpha level was significantly higher in patients with access failure. The distribution of IL-10 and TNF-alpha genotype did not differ among patients with or without access failure. This study could not demonstrate a relationship between genetic polymorphisms and vascular access failure. However, an altered immune response and inflammation might contribute to vascular access failure.
Figures



Similar articles
-
Genetic causation of neointimal hyperplasia in hemodialysis vascular access dysfunction.Semin Dial. 2012 Jan-Feb;25(1):65-73. doi: 10.1111/j.1525-139X.2011.00967.x. Epub 2011 Sep 15. Semin Dial. 2012. PMID: 21917012 Free PMC article. Review.
-
Association of TNF-α -308 G > A and ACE I/D gene polymorphisms in hemodialysis patients with arteriovenous fistula thrombosis.Int Urol Nephrol. 2014 Jul;46(7):1419-25. doi: 10.1007/s11255-013-0580-2. Epub 2013 Oct 15. Int Urol Nephrol. 2014. PMID: 24126814
-
Association of vascular access type with inflammatory marker levels in maintenance hemodialysis patients.Semin Dial. 2014 Jul-Aug;27(4):415-23. doi: 10.1111/sdi.12146. Epub 2013 Oct 9. Semin Dial. 2014. PMID: 24118625
-
Role of the hemodialysis vascular access type in inflammation status and monocyte activation.Int J Artif Organs. 2011 Jun;34(6):481-8. doi: 10.5301/IJAO.2011.8466. Int J Artif Organs. 2011. PMID: 21725929
-
The association of genotype polymorphisms with vascular access patency in hemodialysis patients.J Vasc Access. 2019 May;20(1_suppl):24-30. doi: 10.1177/1129729818758556. Epub 2018 Mar 7. J Vasc Access. 2019. PMID: 29512407 Review.
Cited by
-
Genetic causation of neointimal hyperplasia in hemodialysis vascular access dysfunction.Semin Dial. 2012 Jan-Feb;25(1):65-73. doi: 10.1111/j.1525-139X.2011.00967.x. Epub 2011 Sep 15. Semin Dial. 2012. PMID: 21917012 Free PMC article. Review.
-
Candidate gene analysis of arteriovenous fistula failure in hemodialysis patients.Clin J Am Soc Nephrol. 2013 Aug;8(8):1358-66. doi: 10.2215/CJN.11091012. Epub 2013 Apr 4. Clin J Am Soc Nephrol. 2013. PMID: 23559680 Free PMC article.
-
Association of TNF-α -308 G > A and ACE I/D gene polymorphisms in hemodialysis patients with arteriovenous fistula thrombosis.Int Urol Nephrol. 2014 Jul;46(7):1419-25. doi: 10.1007/s11255-013-0580-2. Epub 2013 Oct 15. Int Urol Nephrol. 2014. PMID: 24126814
-
Bioinformatics identifies predictors of arteriovenous fistula maturation.J Vasc Access. 2024 Jan;25(1):172-186. doi: 10.1177/11297298221102298. Epub 2022 Jun 10. J Vasc Access. 2024. PMID: 35686495 Free PMC article.
-
Local Adipose-Associated Mediators and Adaptations Following Arteriovenous Fistula Creation.Kidney Int Rep. 2018 Mar 2;3(4):970-978. doi: 10.1016/j.ekir.2018.02.008. eCollection 2018 Jul. Kidney Int Rep. 2018. PMID: 29988980 Free PMC article.
References
-
- Rekhter M, Nicholls S, Ferguson M, Gordon D. Cell proliferation in human arteriovenous fistulas used for hemodialysis. Arterioscler Thromb. 1993;13:609–617. - PubMed
-
- Roy-Chaudhury P, Kelly BS, Miller MA, Reaves A, Armstrong J, Nanayakkara N, Heffelfinger SC. Venous neointimal hyperplasia in polytetrafluoroethylene dialysis grafts. Kidney Int. 2001;59:2325–2334. - PubMed
-
- Ram S, Bass K, Abreo K, Baier RJ, Kruger TE. Tumor necrosis factor-alpha -308 gene polymorphism is associated with synthetic hemodialysis graft failure. J Investig Med. 2003;51:19–26. - PubMed
-
- Ozaki K, Ohnishi Y, Iida A, Sekine A, Yamada R, Tsunoda T, Sato H, Hori M, Nakamura Y, Tanaka T. Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction. Nat Genet. 2002;32:650–654. - PubMed
-
- Heine GH, Ulrich C, Sester U, Sester M, Kohler H, Girndt M. Transforming growth factor beta1 genotype polymorphisms determine AV fistula patency in hemodialysis patients. Kidney Int. 2003;64:1101–1107. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical